Implications for clinical decision-making of the NOAH-AFNET 6 and ARTESiA studies: What risk-benefit ratio of anticoagulation in patients with subclinical atrial fibrillation?

Implications for clinical decision-making of the NOAH-AFNET 6 and ARTESiA studies: What risk-benefit ratio of anticoagulation in patients with subclinical atrial fibrillation? / Boriani, G.; Mantovani, M.; Birtolo, C.; Righelli, I.; Gerra, L.. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - 25:4(2024), pp. 215-219. [10.1714/4244.42201]